Oppenheimer & CO Inc Inogen Inc Transaction History

Oppenheimer & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$63.19 - $95.15 $427,669 - $643,975	-6,768 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$90.12 - $152.23 $1,712 - $2,892	19 Added 0.28%	6,768 $646,000
Q4 2018 Jan 29, 2019	BUY	$112.83 - $239.74 $73,677 - $156,550	653 Added 10.71%	6,749 $838,000
Q3 2018 Oct 26, 2018	SELL	$189.1 - $282.92 $189,100 - $282,920	-1,000 Reduced 14.09%	6,096 $1.49 Million
Q2 2018 Aug 10, 2018	SELL	$123.8 - $192.48 $156,483 - $243,294	-1,264 Reduced 15.12%	7,096 $1.32 Million
Q1 2018 May 01, 2018	SELL	$114.22 - $133.22 $4,568 - $5,328	-40 Reduced 0.48%	8,360 $1.03 Million
Q4 2017 Feb 07, 2018	SELL	$93.4 - $128.74 $112,080 - $154,488	-1,200 Reduced 12.5%	8,400 $1 Million
Q3 2017 Nov 09, 2017	BUY	$91.08 - $104.49 $874,368 - $1 Million	9,600	9,600 $913,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $214M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.